
Opinion|Videos|April 11, 2025
Advancing Early Detection: Autoimmune Screening in Type 1 Diabetes
A panelist discusses how autoimmune screening through detection of diabetes-specific autoantibodies serves as a critical tool for identifying pre-symptomatic type 1 diabetes (T1D), enabling earlier intervention before significant beta cell loss occurs and potentially changing the disease trajectory through timely management strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What role does autoimmune screening play in identifying and diagnosing patients with T1D earlier?
- In what patients do you recommend screening for autoantibodies?
- Do you think autoimmune screening initiatives will gain momentum in the next few years?
- How can health care systems and payers improve early screening and diagnosis to better preserve beta cell function?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Zepbound linked to lower healthcare costs in older adults with obesity
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
FDA approves brepocitinib for rare skin disease
4
Biosimilars provide modest cost savings for cancer patients, study finds
5













